Navigation Links
Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
Date:4/23/2009

SAN DIEGO, April 23 /PRNewswire/ -- Accumetrics, Inc. announces today an exclusive distribution agreement with ELITech UK Limited for distribution of the VerifyNow System in the United Kingdom. The distribution agreement marks the beginning of several new distribution channels for the Company as it expands its reach both in scope and geography. ELITech UK will concentrate its efforts on reaching customers in surgery suites and catheterization labs within UK hospitals and other medical centers.

"We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK will help expedite physician access to our products," said Timothy I. Still, President and CEO of the Company. "This partnership marks the beginning of our distribution channel expansion outside the U.S. and demonstrates our focus on rapidly growing our global presence."

"Distribution of the VerifyNow System is extremely complementary to our current portfolio of products, and we are delighted to add them among our customers," said Tim Watson, Managing Director of ELITech UK. "The VerifyNow System is an excellent fit with our expertise within the interventional cardiology market, and we look forward to a long and prosperous partnership with Accumetrics."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, prasugrel, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

About ELITech UK Limited (www.elitechuk.com)

Founded in 2000 ELITech UK Limited is a wholly owned subsidiary of the Pan European marketing and distribution company ELITech Group based in France. The ELITech Group (www.elitechgroup.com) is now a 60 million Euro in vitro diagnostic company with global sales and distribution capabilities in over 100 countries. ELITech offers clinical chemistry, microbiology, immunology and electrophoresis products and operates globally, leveraging products from its own biochemistry and microbiology equipment and reagents manufacturing facilities as well as third party products. In May 2007 ELITech acquired Wescor Inc, Utah USA to broaden its biomedical products platform and to provide a base for business expansion in the USA. In October 2007, ELITech acquired Vital Scientific in the Netherlands to allow the company to offer a complete biochemistry offering.

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    858-404-8260
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
2. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... A newly released report reveals that improving life outcomes for boys and ... face-to-face interactions and online. In “Heard, Not Judged – Insights into the Talents, Realities ... mobile digital devices can be an effective tool to help boys and men of ...
(Date:5/24/2016)... ... ... Growing in popularity, more and more people continue to live their lives ... Whether someone chooses to cut gluten out of their life for personal health reasons ... their shelves with many different gluten-free products all year round. And they take another ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies International, ... to its board of directors. Otterstatter is co-founder, president and CEO of ... innovations that lead to broad-based healthcare solutions. , “Jon knows how to create ...
(Date:5/24/2016)... ... 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered by ... Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold Member. ... is 6:30pm - 7:15pm followed by a small intro to the Oils that can ...
(Date:5/24/2016)... ... 24, 2016 , ... As reported by MassGeneral.org, on May 8 – 9, ... United States . The 64-year-old patient who received the transplant had undergone a partial ... only a natural appearance, but also urinary and sexual function for the patient who ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 According to market ... Growth and Demand Forecast to 2022 - Industry ... Application (Drug Discovery and Development, Proteomics, Clinical Testing, ... Science and Biotechnology, Academic and Research Institute, Hospitals ... global mass spectrometry market was valued ...
(Date:5/23/2016)... , May 23, 2016 Non-invasive ... detection of multiple diseases; ,Technology to be presented at ... Yissum Research Development Company of the Hebrew University ... a research agreement with Aurum Ventures MKI, the technology investment ... of a new diagnostic approach for early detection of ...
(Date:5/23/2016)... FRANCISCO , May 23, 2016 ... to reach USD 5.0 billion by 2022, according to ... increasing generation of medical waste coupled with the lack ... industry is expected to drive the demand for reprocessed ... these devices as compared to that of the original ...
Breaking Medicine Technology: